Risk factors for acquiring HCV at a healthcare center in Hidalgo, Mexico.

Factores de riesgo para adquirir VHC en una institución de salud en Hidalgo.

Journal

Revista de gastroenterologia de Mexico (English)
ISSN: 2255-534X
Titre abrégé: Rev Gastroenterol Mex (Engl Ed)
Pays: Mexico
ID NLM: 101778603

Informations de publication

Date de publication:
Historique:
received: 08 08 2017
revised: 11 02 2018
accepted: 22 02 2018
pubmed: 14 6 2018
medline: 14 6 2019
entrez: 14 6 2018
Statut: ppublish

Résumé

The approach to HCV infection begins with the directed search for risk factors linked to its acquisition. Therefore, our primary aim was to identify the prevalence of risk factors associated with HCV infections in insured individuals seen at the Hidalgo delegation of the IMSS. An observational, descriptive, cross-sectional study was conducted through validated surveys that identified major and minor risk factors. In cases of major risk factors, the Advanced Quality™ RAPID-ANTI-HCV TEST Accutrack A total of 528 insured individuals were surveyed (95%CI with a 5% margin of error). Two hundred eighty-two rapid tests were performed. Five of them were positive (0.94%) and belonged to the patients in the dialysis/hemodialysis group. A total of 71.2% persons had positive risk factors. The association of 2 or more factors varied from 2 to 8 factors present at the same time. Of the entire study population, 6.25% presented with 4 risk factors and 4.35% presented with 5 risk factors at the same time. Nearly three quarters of the individuals surveyed were exposed to HCV acquisition. The association of 2 or more risk factors in patients demonstrated their collective potentiality for acquiring HCV. We identified persons receiving treatment with dialysis/hemodialysis and those with high-risk sexual practices as vulnerable groups for HCV infection and suggest that they receive promotion and prevention activities, as well as public policy management.

Identifiants

pubmed: 29895448
pii: S0375-0906(18)30067-3
doi: 10.1016/j.rgmx.2018.02.012
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

36-43

Informations de copyright

Copyright © 2018 Asociación Mexicana de Gastroenterología. Publicado por Masson Doyma México S.A. All rights reserved.

Auteurs

R Contreras-Omaña (R)

Centro de Investigación en Enfermedades Hepáticas y Gastroenterología, Hidalgo, México. Electronic address: rulosofo@gmail.com.

F J García-Lemus (FJ)

Centro de Investigación en Enfermedades Hepáticas y Gastroenterología, Hidalgo, México; Universidad Autónoma del Estado de Hidalgo, México.

A García-Camacho (A)

Centro de Investigación en Enfermedades Hepáticas y Gastroenterología, Hidalgo, México; Universidad Autónoma del Estado de Hidalgo, México.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH